Litiasis medicamentosa en pacientes Vih+ eb tratamietno con Indinavir

Juan Escudero, Joaquín Ulises; Emilio López Alcina, Emilio; Ordoño Domínguez, Felipe; Fabuel Deltoro, Milagros; Serrano de la Cruz Torrijos, Francisco; Montoliu García, Ana; Ramada Benlloch, Francisco; Marqués Vidal, Emilio.
Arch. esp. urol. (Ed. impr.) ; 61(1): 35-40, ene.-feb. 2008. ilus
Artículo en Es | IBECS (España) | ID: ibc-059043

Documentos relacionados

  1. [Urinary calculi and crystalluria in HIV+ patients treated with indinavir sulfate].
  2. [Indinavir and renal lithiasis].
  3. [Indinavir urolithiasis in HIV-positive patients. Treatment and prophylaxis].
  4. Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients.
  5. Calcium-to-Citrate Ratio Distinguishes Solitary and Recurrent Urinary Stone Forming Children.
  6. Stone symptoms and urinary deposits.
  7. [Urinary stone disease. Part V. Drugs used for metaphylaxis of urinary stone disease].
  8. [Clinical value of Canephron N after surgical treatment of urinary stone disease].
  9. [Prevention of urolithiasis using febuxostat in patients with metabolic syndrome].
  10. Composition of Urine Collected from Non-Stone-Forming Chinese Persons during Different Short-Term Periods of the Day.